[Studies on the compatibility of tretinoin after systemic and topical application].
D000152:Acne Vulgaris / Q000188:drug therapy; D000284:Administration, Oral; D000287:Administration, Topical; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects; D001786:Blood Glucose; D001794:Blood Pressure / Q000187:drug effects; D002199:Capillary Permeability / Q000187:drug effects; D002415:Cats; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004361:Drug Tolerance; D004558:Electric Stimulation; D004890:Erythema / Q000188:drug therapy; D005260:Female; D005782:Gels; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012867:Skin / Q000187:drug effects; D012869:Skin Absorption; D014801:Vitamin A / Q000494:pharmacology*
D001786:Blood Glucose; D005782:Gels; D014801:Vitamin A; D000469:Alkaline Phosphatase
Untersuchungen zur Verträglichkeit von Tretinoin nach systemischer und lokaler Applikation 2. Mitteilung: Pharmakologische Untersuchungen